rs1058219

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001382347.1(MYO5A):​c.3736C>T​(p.Arg1246Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 1,614,020 control chromosomes in the GnomAD database, including 21,616 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1246P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.15 ( 1810 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19806 hom. )

Consequence

MYO5A
NM_001382347.1 missense

Scores

8
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.07

Publications

30 publications found
Variant links:
Genes affected
MYO5A (HGNC:7602): (myosin VA) This gene is one of three myosin V heavy-chain genes, belonging to the myosin gene superfamily. Myosin V is a class of actin-based motor proteins involved in cytoplasmic vesicle transport and anchorage, spindle-pole alignment and mRNA translocation. The protein encoded by this gene is abundant in melanocytes and nerve cells. Mutations in this gene cause Griscelli syndrome type-1 (GS1) and neuroectodermal melanolysosomal disease, or Elejalde disease. [provided by RefSeq, Sep 2023]
MYO5A Gene-Disease associations (from GenCC):
  • Griscelli syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Griscelli syndrome type 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016999841).
BP6
Variant 15-52351367-G-A is Benign according to our data. Variant chr15-52351367-G-A is described in ClinVar as Benign. ClinVar VariationId is 255650.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO5ANM_001382347.1 linkc.3736C>T p.Arg1246Cys missense_variant Exon 28 of 42 ENST00000399233.7 NP_001369276.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO5AENST00000399233.7 linkc.3736C>T p.Arg1246Cys missense_variant Exon 28 of 42 5 NM_001382347.1 ENSP00000382179.4 Q9Y4I1-3F8WE88

Frequencies

GnomAD3 genomes
AF:
0.150
AC:
22847
AN:
152048
Hom.:
1816
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.164
Gnomad ASJ
AF:
0.220
Gnomad EAS
AF:
0.191
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.123
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.167
Gnomad OTH
AF:
0.178
GnomAD2 exomes
AF:
0.156
AC:
38829
AN:
249556
AF XY:
0.156
show subpopulations
Gnomad AFR exome
AF:
0.109
Gnomad AMR exome
AF:
0.136
Gnomad ASJ exome
AF:
0.216
Gnomad EAS exome
AF:
0.184
Gnomad FIN exome
AF:
0.125
Gnomad NFE exome
AF:
0.165
Gnomad OTH exome
AF:
0.181
GnomAD4 exome
AF:
0.163
AC:
237836
AN:
1461854
Hom.:
19806
Cov.:
34
AF XY:
0.162
AC XY:
118133
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.105
AC:
3507
AN:
33480
American (AMR)
AF:
0.139
AC:
6233
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
5725
AN:
26136
East Asian (EAS)
AF:
0.171
AC:
6790
AN:
39700
South Asian (SAS)
AF:
0.152
AC:
13141
AN:
86258
European-Finnish (FIN)
AF:
0.128
AC:
6863
AN:
53420
Middle Eastern (MID)
AF:
0.206
AC:
1186
AN:
5764
European-Non Finnish (NFE)
AF:
0.165
AC:
184005
AN:
1111978
Other (OTH)
AF:
0.172
AC:
10386
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
12286
24573
36859
49146
61432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6586
13172
19758
26344
32930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.150
AC:
22838
AN:
152166
Hom.:
1810
Cov.:
32
AF XY:
0.148
AC XY:
10988
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.111
AC:
4592
AN:
41510
American (AMR)
AF:
0.163
AC:
2499
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
764
AN:
3470
East Asian (EAS)
AF:
0.192
AC:
994
AN:
5184
South Asian (SAS)
AF:
0.154
AC:
742
AN:
4824
European-Finnish (FIN)
AF:
0.123
AC:
1299
AN:
10592
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.167
AC:
11384
AN:
67980
Other (OTH)
AF:
0.176
AC:
372
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
993
1986
2979
3972
4965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.163
Hom.:
4757
Bravo
AF:
0.153
TwinsUK
AF:
0.166
AC:
617
ALSPAC
AF:
0.169
AC:
650
ESP6500AA
AF:
0.102
AC:
414
ESP6500EA
AF:
0.168
AC:
1402
ExAC
AF:
0.154
AC:
18638
Asia WGS
AF:
0.145
AC:
506
AN:
3478
EpiCase
AF:
0.173
EpiControl
AF:
0.179

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Griscelli syndrome type 1 Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 1997
OMIM
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.49
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.48
T;.;T;T;.;T;T;T;T
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.075
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Uncertain
0.91
D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0017
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
L;L;.;.;.;.;.;.;.
PhyloP100
2.1
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-3.5
D;D;.;D;D;D;D;D;D
REVEL
Benign
0.10
Sift
Uncertain
0.0060
D;D;.;D;D;D;D;D;D
Sift4G
Uncertain
0.018
D;D;D;D;D;D;D;T;T
Polyphen
0.59
P;D;.;.;.;.;.;.;.
Vest4
0.16
MPC
0.77
ClinPred
0.033
T
GERP RS
2.3
Varity_R
0.14
gMVP
0.42
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1058219; hg19: chr15-52643564; COSMIC: COSV62559286; API